JPH04320681A - Culture of animal cell - Google Patents

Culture of animal cell

Info

Publication number
JPH04320681A
JPH04320681A JP3088283A JP8828391A JPH04320681A JP H04320681 A JPH04320681 A JP H04320681A JP 3088283 A JP3088283 A JP 3088283A JP 8828391 A JP8828391 A JP 8828391A JP H04320681 A JPH04320681 A JP H04320681A
Authority
JP
Japan
Prior art keywords
cells
culture
ascorbic acid
adhesion
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3088283A
Other languages
Japanese (ja)
Inventor
Keizo Hanada
花田 敬三
Tadashi Shimoda
下田 正
Katsuhiko Mukai
克彦 向井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP3088283A priority Critical patent/JPH04320681A/en
Publication of JPH04320681A publication Critical patent/JPH04320681A/en
Pending legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PURPOSE:To promote multiplication, to improve number of cells reached and to improve production of useful substance in culture of cells of adhesion dependent animal. CONSTITUTION:In culturing cells of adhesion dependent animal by using micro carrier, hollow fiber or microcapsules, ascorbic acid or a derivative thereof is added to the cells and the cells are cultured.

Description

【発明の詳細な説明】[Detailed description of the invention]

【0001】0001

【産業上の利用分野】本発明は、接着依存性動物細胞の
培養方法に関する。
FIELD OF THE INVENTION The present invention relates to a method for culturing adhesion-dependent animal cells.

【0002】0002

【従来の技術】二倍体細胞、腫瘍細胞や遺伝子組み換え
動物細胞を用いて有用物質が産生されている。培養方法
としてルー瓶もしくはローラー瓶を用いる方法が知られ
ているが、この方法では大量培養することは極めて困難
と考えられている。すなわち、この方法では、細胞はル
ー瓶の底面もしくはローラー瓶の内側面に単層に増殖す
るだけであるため、大量培養には多量の瓶を必要とし適
さない。また、pHや培地中の溶存酸素濃度等を一定に
制御することはほとんど不可能である。そのため大量で
かつ培養条件を一定に制御することが可能となる方法が
開発されている。接着依存性動物細胞をマイクロキャリ
ヤーもしくは中空糸に接着培養、あるいはマイクロカプ
セルに固定化培養する方法等がある。これらの方法は、
スケールアップする場合増殖速度が低下し種細胞数が不
足するため本培養の到達細胞数が低下することがしばし
ば生じる。
BACKGROUND OF THE INVENTION Useful substances are produced using diploid cells, tumor cells and genetically modified animal cells. As a culture method, a method using a roux bottle or a roller bottle is known, but it is considered extremely difficult to perform large-scale culture using this method. That is, in this method, the cells only grow in a single layer on the bottom of the roux bottle or the inner surface of the roller bottle, and therefore a large number of bottles are required for mass culture, making it unsuitable. Furthermore, it is almost impossible to control the pH, dissolved oxygen concentration, etc. in the culture medium to a constant level. Therefore, methods have been developed that allow for large quantities and constant control of culture conditions. Methods include culturing adhesion-dependent animal cells on microcarriers or hollow fibers, or immobilizing and culturing them in microcapsules. These methods are
When scaling up, the number of cells reached in the main culture often decreases because the proliferation rate decreases and the number of seed cells becomes insufficient.

【0003】0003

【発明が解決しようとする課題】本発明の目的は、動物
細胞を大量培養する場合、増殖促進と到達細胞数の向上
を図ることにより、培養系を安定させひいては有用物質
の産生を向上させる培養法を提供することにある。
[Problems to be Solved by the Invention] The purpose of the present invention is to provide a culture system that stabilizes the culture system and improves the production of useful substances by promoting proliferation and increasing the number of cells reached when culturing animal cells in large quantities. It is about providing law.

【0004】0004

【課題を解決するための手段】上記目的は、以下の本発
明により達成される。すなわち本発明は、接着依存性動
物細胞を、マイクロキャリヤーもしくは中空糸に接着培
養、あるいはマイクロカプセルに固定化培養する際に、
アスコルビン酸またはその誘導体を添加することを特徴
とする動物細胞の培養方法である。接着依存性細胞とは
ヒトあるいは動物由来の線維芽細胞、血管内皮細胞、上
皮細胞および各種ガン細胞をさす。また、接着依存性細
胞の遺伝子組み換え体も含まれる。これらのなかで特に
線維芽細胞が好ましい。
[Means for Solving the Problems] The above object is achieved by the following present invention. That is, the present invention provides a method for culturing adhesion-dependent animal cells on microcarriers or hollow fibers, or immobilizing them on microcapsules.
A method for culturing animal cells characterized by adding ascorbic acid or a derivative thereof. Adhesion-dependent cells refer to human or animal-derived fibroblasts, vascular endothelial cells, epithelial cells, and various cancer cells. It also includes genetically modified adhesion-dependent cells. Among these, fibroblasts are particularly preferred.

【0005】本発明で使用するマイクロキャリアーは、
マトリックス素材はコラーゲン、ゼラチン、セルロース
、架橋デキストラン、ポリスチレンのような合成樹脂か
らなり、荷電基としてジメチルアミノプロピル、ジメチ
ルアミノエチル、トリメチルハイドロキシアミノプロピ
ル、負荷電が付加されているものが好ましい。また、マ
トリックス素材をコラーゲンやゼラチンでコートしたも
のも使用される。市販品として、架橋デキストランにジ
メチルアミノエチルを付加した“Cytodex−1”
(ファルマシア社)、架橋デキストランに変性コラーゲ
ンをコートした“Cytodex−3”(ファルマシア
社)がある。中空糸としては、修飾セルロースを使用し
た物がある。市販品は、“Vitafiber”(アミ
コン社)がある。マイクロカプセルは、水透過性のある
ゲルを形成するコラーゲンやアルギン酸ソーダを用いて
、内部に細胞を包埋して作成する(A.Klausne
r,Bio/technol.,1,736(1983
)。
[0005] The microcarrier used in the present invention is
The matrix material is made of a synthetic resin such as collagen, gelatin, cellulose, crosslinked dextran, or polystyrene, and preferably has a negatively charged charged group such as dimethylaminopropyl, dimethylaminoethyl, trimethylhydroxyaminopropyl. Matrix materials coated with collagen or gelatin are also used. As a commercial product, “Cytodex-1” is a product with dimethylaminoethyl added to cross-linked dextran.
(Pharmacia) and "Cytodex-3" (Pharmacia), which is a cross-linked dextran coated with denatured collagen. As the hollow fiber, there is one using modified cellulose. A commercially available product is "Vitafiber" (Amicon). Microcapsules are created by embedding cells inside using collagen or sodium alginate, which form a water-permeable gel (A. Klausne
r, Bio/technol. , 1,736 (1983
).

【0006】接着依存性動物細胞を培養するには、種細
胞を、マイクロキャリアービーズや中空糸に接種し、ま
たはマイクロカプセル固定化細胞を作成し培養する。培
地組成、血清濃度等は、培養すべき細胞の種類、細胞濃
度等に応じて適当に選ばれる。調製した培地にアスコル
ビン酸もしくはアスコルビン酸誘導体を添加する。本発
明で用いる培地は、通常のものが使用できる。細胞に適
した培地を、適当に選択することが好ましい。培養中、
アスコルビン酸もしくはアスコルビン酸誘導体を含む培
地で適宜交換を行い、数日間〜20日間培養する。細胞
がコンフルエントになるまで培養を続ける。アスコルビ
ン酸は、中性溶液中、37℃、酸素条件下ではすみやか
に酸化分解される。したがって、アスコルビン酸を培養
に用いる場合は、毎日添加するなど頻回添加が好ましい
。培養に用いるアスコルビン酸としは、培養条件下で安
定かつアスコルビン酸作用をもつ誘導体が好ましい。 たとえば、L−アスコルビン酸リン酸エステルや(畑ら
、1988  第35回コラーゲン研究会抄録  p8
5〜89)、L−アスコルビン酸グルコシドが挙げられ
る。添加する濃度は、アスコルビン酸、もしくはその誘
導体を0.05〜10mMの範囲で使用する。好ましく
は、0.5〜3mMで使用する。それぞれの誘導体につ
いては、培養に適した濃度を適宜選択することが好まし
い。
To culture adhesion-dependent animal cells, seed cells are inoculated onto microcarrier beads or hollow fibers, or microcapsule-immobilized cells are prepared and cultured. The medium composition, serum concentration, etc. are appropriately selected depending on the type of cells to be cultured, cell concentration, etc. Ascorbic acid or an ascorbic acid derivative is added to the prepared medium. A conventional medium can be used in the present invention. It is preferable to appropriately select a medium suitable for the cells. During cultivation,
The culture medium is appropriately replaced with a medium containing ascorbic acid or an ascorbic acid derivative, and cultured for several to 20 days. Continue culturing until cells are confluent. Ascorbic acid is rapidly oxidized and decomposed in a neutral solution at 37° C. under oxygen conditions. Therefore, when ascorbic acid is used for culture, it is preferable to add it frequently, such as daily. The ascorbic acid used for culture is preferably a derivative that is stable under culture conditions and has ascorbic acid action. For example, L-ascorbic acid phosphate ester (Hata et al., 1988, Abstracts of the 35th Collagen Study Group, p. 8)
5-89) and L-ascorbic acid glucoside. Ascorbic acid or a derivative thereof is added at a concentration of 0.05 to 10 mM. Preferably, it is used at 0.5-3mM. For each derivative, it is preferable to appropriately select a concentration suitable for culture.

【0007】[0007]

【実施例】以下実施例を挙げて本発明を具体的に説明す
るが、これらにより本発明が限定されるものではない。 実施例1 胎児牛血清5%、ジエチルアミノエチル基を有する架橋
デキストランマイクロキャリア(“Cytodex−1
”(ファルマシア社))5g/Lを含むイーグルMEM
系培地  2Lにアスコルビン酸リン酸エステル0.5
mMを添加、または無添加とし、ヒト線維芽細胞を約3
×105 個/mlの割合で接種したスピナーフラスコ
でゆるく撹拌しながら、37℃、pH7.2、20%飽
和酸素濃度で6日間培養した。途中、1日目、3日目、
5日目に培地交換を行った。到達細胞数は、無添加の場
合3.2×106 個/ml、0.5mM添加の場合3
.9×106 個/mlであった。
[Examples] The present invention will be specifically explained below with reference to Examples, but the present invention is not limited by these. Example 1 Fetal bovine serum 5%, cross-linked dextran microcarriers with diethylaminoethyl groups (“Cytodex-1
Eagle MEM containing 5g/L (Pharmacia)
System medium: 0.5 ascorbic acid phosphate per 2L
With or without addition of mM, human fibroblast cells were
The cells were cultured for 6 days at 37° C., pH 7.2, and 20% saturated oxygen concentration with gentle stirring in a spinner flask inoculated at a rate of 10 5 cells/ml. On the way, 1st day, 3rd day,
The medium was replaced on the 5th day. The number of cells reached is 3.2 x 106 cells/ml without addition, and 3 with 0.5mM addition.
.. It was 9 x 106 cells/ml.

【0008】[0008]

【発明の効果】本発明によれば、マイクロキャリヤー、
中空糸やマイクロカプセルを用いた接着依存性動物細胞
培養において、細胞増殖を促進させ、到達細胞数を上げ
ることができる。したがって、工業生産規模にスケール
アップする際の培養系の安定化を図る事ができ、ひいて
は有用物質の産生を向上させることができる。
[Effects of the Invention] According to the present invention, microcarriers,
In adhesion-dependent animal cell culture using hollow fibers or microcapsules, cell proliferation can be promoted and the number of cells reached can be increased. Therefore, it is possible to stabilize the culture system when scaling up to an industrial production scale, and as a result, the production of useful substances can be improved.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】  接着依存性動物細胞を、マイクロキャ
リヤーもしくは中空糸で接着培養、あるいはマイクロカ
プセルで固定化培養する際に、アスコルビン酸またはそ
の誘導体を添加し培養することを特徴とする動物細胞の
培養方法。
[Claim 1] A method for producing animal cells characterized in that adhesion-dependent animal cells are cultured in a microcarrier or hollow fiber, or immobilized in a microcapsule, with the addition of ascorbic acid or a derivative thereof. Culture method.
JP3088283A 1991-04-19 1991-04-19 Culture of animal cell Pending JPH04320681A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3088283A JPH04320681A (en) 1991-04-19 1991-04-19 Culture of animal cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3088283A JPH04320681A (en) 1991-04-19 1991-04-19 Culture of animal cell

Publications (1)

Publication Number Publication Date
JPH04320681A true JPH04320681A (en) 1992-11-11

Family

ID=13938579

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3088283A Pending JPH04320681A (en) 1991-04-19 1991-04-19 Culture of animal cell

Country Status (1)

Country Link
JP (1) JPH04320681A (en)

Similar Documents

Publication Publication Date Title
US4994388A (en) Collagen-coated polystyrene microcarrier beads
US4975377A (en) Cell growth chambers and method of use thereof
US4024020A (en) Method of cell culture on polyacrylonitrile surface
EP0529751A1 (en) Cell culture substrate, test material for cell culture and preparations thereof
Van der Velden-de Groot Microcarrier technology, present status and perspective
CA2075766C (en) Carrier for animal cell culture
Nilsson Microcarrier cell culture
US5114855A (en) Method for aggregating cells with small microspheres
Voigt et al. Hybridoma cell growth and anti-neuroblastoma monoclonal antibody production in spinner flasks using a protein-free medium with microcarriers
Nguyen et al. Tissue regeneration of human mesenchymal stem cells on porous gelatin micro-carriers by long-term dynamic in vitro culture
SENOO et al. Three‐dimensional structure of extracellular matrix reversibly regulates morphology, proliferation and collagen metabolism of perisinusoidal stellate cells (vitamin A‐storing cells)
Nakajima et al. Entrapment of Lavandula vera cells with synthetic resin prepolymers and its application to pigment production
Jain et al. Supermacroporous polymer‐based cryogel bioreactor for monoclonal antibody production in continuous culture using hybridoma cells
Kong et al. High cell density and productivity culture of Chinese hamster ovary cells in a fluidized bed bioreactor
JPH04320681A (en) Culture of animal cell
Acevedo et al. A mathematical model for the design of fibrin microcapsules with skin cells
Kratje et al. Evaluation of production of recombinant human interleukin‐2 in fluidized bed bioreactor
WO1989006686A1 (en) Enhanced production of cellular proteins using butyrate
Duvar et al. Scale up cultivation of primary human umbilical vein endothelial cells on microcarriers from spinner vessels to bioreactor fermentation
Wen‐tao et al. Optimization of the cell seeding density and modeling of cell growth and metabolism using the modified Gompertz model for microencapsulated animal cell culture
JPS6225974A (en) Gelatinous composition consisting of collagen
Murdin et al. Growth and metabolism of hybridomas immobilized in packed beds: comparison with static and suspension cultures
Shen et al. Hybridoma cells in a protein-free medium within a composite gel perfusion bioreactor
KR101639454B1 (en) Scalable process for culturing per.c6 cells and producing products therefrom
Lazar et al. Production of biologicals by animal cells immobilized in polyurethane foam matrix